InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.375 0.005 (1.32%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$115 Change of Director's Interest Notices 14 Oct 2025 6:21PM $0.430 $0.375 fallen by 12.79%
$115 Notification of cessation of securities - RCE 8 Oct 2025 8:34AM $0.420 $0.375 fallen by 10.71%
$115 Update - Notification of buy-back - RCE 8 Oct 2025 8:33AM $0.420 $0.375 fallen by 10.71%
$115 Update - Notification of buy-back - RCE 7 Oct 2025 4:41PM $0.420 $0.375 fallen by 10.71%
$115 Notice of Annual General Meeting/Proxy Form 3 Oct 2025 11:54AM $0.440 $0.375 fallen by 14.77%
$115 Patient Dosing Underway in Ph 3 Indonesia DFI Trial 25 Sep 2025 9:49AM $0.390 $0.375 fallen by 3.85%
$115 2025 Annual General Meeting 15 Sep 2025 4:46PM $0.405 $0.375 fallen by 7.41%
$115 Appendix 4G 29 Aug 2025 7:29PM $0.420 $0.375 fallen by 10.71%
$115 Annual Report to Shareholders 29 Aug 2025 7:29PM $0.420 $0.375 fallen by 10.71%
$115 Preliminary Final Report 29 Aug 2025 7:27PM $0.420 $0.375 fallen by 10.71%
$115 Preliminary Final Report 29 Aug 2025 7:27PM $0.420 $0.375 fallen by 10.71%
$115 Notification regarding unquoted securities - RCE 25 Aug 2025 7:24PM $0.430 $0.375 fallen by 12.79%
$115 R327G Highly Effective in Burn Wounds Model 12 Aug 2025 10:53AM $0.400 $0.375 fallen by 6.25%
$115 Abstract & Poster Presentation at US Military Symposium 2025 5 Aug 2025 9:44AM $0.375 $0.375 fallen by 0%
$115 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 6:18PM $0.388 $0.375 fallen by 3.23%
$115 Change in substantial holding 24 Jul 2025 9:05AM $0.363 $0.375 risen by 3.45%
$115 Cleansing Notice 14 Jul 2025 6:10PM $0.330 $0.375 risen by 13.64%
$115 Application for quotation of securities - RCE 14 Jul 2025 5:57PM $0.330 $0.375 risen by 13.64%
$115 Proposed issue of securities - RCE 17 Jun 2025 10:53AM $0.305 $0.375 risen by 22.95%
$115 Recce Signs Debt Facility with Avenue Capital Group 17 Jun 2025 10:29AM $0.305 $0.375 risen by 22.95%
$115 Change in substantial holding 12 Jun 2025 2:02PM $0.330 $0.375 risen by 13.64%
$115 Change in substantial holding 11 Jun 2025 9:42AM $0.350 $0.375 risen by 7.14%
$115 Cleansing Notice 10 Jun 2025 12:27PM $0.320 $0.375 risen by 17.19%
$115 Application for quotation of securities - RCE 10 Jun 2025 11:10AM $0.318 $0.375 risen by 18.11%
$115 Becoming a substantial holder 6 Jun 2025 2:16PM $0.330 $0.375 risen by 13.64%

51 - 75 of 724 results

Page 3 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.